Skip to content

association between dystrophia myotonica type II and autoimmune disease

association between dystrophia myotonica type II and autoimmune disease - DMII and autoimmune disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON30830
Enrollment
64
Registered
2007-10-09
Start date
2007-09-01
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dystrophia myotonica type II muscle disorder

Interventions

None listed

Sponsors

Sint Maartenskliniek
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: dystrophia myotonica type II informed consent

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
frequency of autoimmune disease according to clinical criteria or classification criteria in both cohorts

Secondary

MeasureTime frame
frequency of autoantibody fromation in both cohorts

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)